M

Merrimack Pharmaceuticals

59 employees

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Oncology and Network Biology
Pharmaceutical

Date founded

2000

Funding rounds raised

Total raised

$77M

from 10 investors over 10 rounds

M

Merrimack Pharmaceuticals raised $25M on July 2, 2018

Investors: Hercules Capital, Inc.

M

Merrimack Pharmaceuticals raised $77M on April 14, 2011

Investors: Jennison Associates LLC and Crocker Ventures, LLC

M

Merrimack Pharmaceuticals raised $65M on April 3, 2006

Investors: Jennison Associates LLC

M

Merrimack Pharmaceuticals raised undisclosed on March 28, 2006

Investors: University Venture Fund

M

Merrimack Pharmaceuticals raised $9M on June 20, 2005

Investors: Hercules Capital, Inc.

M

Merrimack Pharmaceuticals raised $28M on April 20, 2005

Investors: Unilever Ventures

M

Merrimack Pharmaceuticals raised $28M on May 5, 2004

Investors: Wharton Capital Partners LTD and rEVO Biologics

M

Merrimack Pharmaceuticals raised undisclosed on March 25, 2004

Investors: National Institutes of Health

FAQ